Ross Osborn
Stock Analyst at Cantor Fitzgerald
(1.85)
# 3,262
Out of 4,989 analysts
116
Total ratings
27.78%
Success rate
-4.82%
Average return
Main Sectors:
Stocks Rated by Ross Osborn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORGO Organogenesis Holdings | Maintains: Overweight | $7 → $9 | $4.72 | +90.68% | 4 | Aug 8, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Neutral | $92 → $95 | $92.62 | +2.57% | 2 | Aug 6, 2025 | |
| CVRX CVRx, Inc. | Reiterates: Overweight | $11 | $7.53 | +46.18% | 3 | Aug 5, 2025 | |
| SIBN SI-BONE | Reiterates: Overweight | $25 | $14.84 | +68.46% | 10 | Aug 5, 2025 | |
| MDXG MiMedx Group | Maintains: Overweight | $11 → $12 | $7.20 | +66.67% | 5 | Jul 31, 2025 | |
| BVS Bioventus | Initiates: Overweight | $12 | $6.96 | +72.54% | 1 | Jul 7, 2025 | |
| XGN Exagen | Maintains: Overweight | $8 → $7 | $9.86 | -29.01% | 6 | May 15, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Overweight | $2 | $1.08 | +85.19% | 6 | May 15, 2025 | |
| NPCE NeuroPace | Reiterates: Overweight | $17 | $10.43 | +63.07% | 6 | May 14, 2025 | |
| NNOX Nano-X Imaging | Maintains: Overweight | $12 → $9 | $4.02 | +123.88% | 11 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $46 | $33.83 | +35.99% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $8 | $1.09 | +633.94% | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $24 | $17.70 | +35.59% | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $4 | $1.51 | +164.90% | 4 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $9 | $12.39 | -27.36% | 7 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $4.90 | +83.67% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $21 | $5.92 | +254.73% | 10 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $4.99 | +220.64% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $3.5 | $1.29 | +172.37% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $2.5 | $0.62 | +306.44% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.63 | - | 7 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $8.61 | $0.44 | +1,878.86% | 2 | Aug 18, 2023 |
Organogenesis Holdings
Aug 8, 2025
Maintains: Overweight
Price Target: $7 → $9
Current: $4.72
Upside: +90.68%
LeMaitre Vascular
Aug 6, 2025
Maintains: Neutral
Price Target: $92 → $95
Current: $92.62
Upside: +2.57%
CVRx, Inc.
Aug 5, 2025
Reiterates: Overweight
Price Target: $11
Current: $7.53
Upside: +46.18%
SI-BONE
Aug 5, 2025
Reiterates: Overweight
Price Target: $25
Current: $14.84
Upside: +68.46%
MiMedx Group
Jul 31, 2025
Maintains: Overweight
Price Target: $11 → $12
Current: $7.20
Upside: +66.67%
Bioventus
Jul 7, 2025
Initiates: Overweight
Price Target: $12
Current: $6.96
Upside: +72.54%
Exagen
May 15, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $9.86
Upside: -29.01%
Lucid Diagnostics
May 15, 2025
Reiterates: Overweight
Price Target: $2
Current: $1.08
Upside: +85.19%
NeuroPace
May 14, 2025
Reiterates: Overweight
Price Target: $17
Current: $10.43
Upside: +63.07%
Nano-X Imaging
Apr 1, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $4.02
Upside: +123.88%
Mar 26, 2025
Reiterates: Overweight
Price Target: $46
Current: $33.83
Upside: +35.99%
Mar 7, 2025
Reiterates: Overweight
Price Target: $8
Current: $1.09
Upside: +633.94%
Mar 5, 2025
Reiterates: Overweight
Price Target: $24
Current: $17.70
Upside: +35.59%
Feb 21, 2025
Reiterates: Overweight
Price Target: $4
Current: $1.51
Upside: +164.90%
Jan 16, 2025
Reiterates: Overweight
Price Target: $9
Current: $12.39
Upside: -27.36%
Jan 7, 2025
Initiates: Overweight
Price Target: $9
Current: $4.90
Upside: +83.67%
Dec 24, 2024
Reiterates: Overweight
Price Target: $21
Current: $5.92
Upside: +254.73%
Nov 5, 2024
Reiterates: Overweight
Price Target: $16
Current: $4.99
Upside: +220.64%
Aug 8, 2024
Reiterates: Overweight
Price Target: $3.5
Current: $1.29
Upside: +172.37%
May 16, 2024
Reiterates: Overweight
Price Target: $2.5
Current: $0.62
Upside: +306.44%
Apr 12, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Aug 18, 2023
Reiterates: Neutral
Price Target: $8.61
Current: $0.44
Upside: +1,878.86%